Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Sell
35,484
-3,704
-9% -$1.27M 0.14% 116
2026
Q1
$13.8M Buy
39,188
+4,962
+14% +$1.77M 0.15% 111
2025
Q4
$11.2M Sell
34,226
-24,091
-41% -$7.64M 0.14% 121
2025
Q3
$16.5M Buy
58,317
+9,823
+20% +$2.85M 0.22% 84
2025
Q2
$13.5M Buy
48,494
+33,362
+220% +$9.45M 0.21% 80
2025
Q1
$4.71M Buy
15,132
+312
+2% +$92.1K 0.14% 91
2024
Q4
$3.86M Buy
14,820
+281
+2% +$83.4K 0.11% 106
2024
Q3
$4.68M Sell
14,539
-107
-0.7% -$35K 0.12% 79
2024
Q2
$4.58M Buy
14,646
+1
+0% +$294 0.13% 77
2024
Q1
$4.16M Sell
14,645
-291
-2% -$85.1K 0.11% 99
2023
Q4
$4.3M Sell
14,936
-2,575
-15% -$702K 0.12% 84
2023
Q3
$4.71M Buy
17,511
+325
+2% +$81.1K 0.14% 73
2023
Q2
$3.82M Buy
17,186
+808
+5% +$187K 0.11% 78
2023
Q1
$3.96M Sell
16,378
-9,848
-38% -$2.42M 0.12% 74
2022
Q4
$6.83M Sell
26,226
-5,134
-16% -$1.38M 0.19% 63
2022
Q3
$7.07M Buy
31,360
+16,951
+118% +$4.11M 0.22% 48
2022
Q2
$3.51M Buy
14,409
+9,489
+193% +$2.33M 0.11% 76
2022
Q1
$1.18M Buy
4,920
+365
+8% +$83.9K 0.03% 201
2021
Q4
$1.02M Sell
4,555
-26,269
-85% -$5.54M 0.03% 203
2021
Q3
$6.5M Buy
30,824
+18,986
+160% +$4.37M 0.17% 67
2021
Q2
$2.89M Buy
11,838
+6,537
+123% +$1.61M 0.09% 116
2021
Q1
$1.32M Buy
+5,301
New +$1.26M 0.05% 167
2020
Q4
Sell
-8,852
Closed -$2.23M 104
2020
Q3
$2.23M Buy
8,852
+2,984
+51% +$739K 0.08% 117
2020
Q2
$1.38M Buy
5,868
+232
+4% +$52.9K 0.03% 194
2020
Q1
$1.14M Buy
5,636
+138
+3% +$30.1K 0.06% 120
2019
Q4
$1.32M Sell
5,498
-60
-1% -$13.2K 0.06% 138
2019
Q3
$1.07M Sell
5,558
-21,276
-79% -$4.08M 0.04% 112
2019
Q2
$4.95M Buy
26,834
+6,384
+31% +$1.14M 0.14% 46
2019
Q1
$3.85M Buy
+20,450
New +$3.91M 0.14% 56
2018
Q3
Sell
-11,453
Closed -$2.11M 260
2018
Q2
$2.11M Sell
11,453
-277
-2% -$49K 0.09% 71
2018
Q1
$2M Buy
11,730
+8,099
+223% +$1.49M 0.09% 67
2017
Q4
$582K Buy
+3,631
New +$643K 0.04% 138

Other funds holding AMGN

Horizon Investments's AMGN Position: Q2 2026 in Review

Horizon Investments reduced its Amgen (AMGN) stake by 9.5% in Q2 2026, selling an estimated $1.27M and leaving 35,484 shares worth $12.8M. The position accounts for 0.14% of the portfolio, ranked #116.

Horizon Investments first reported a position in AMGN in Q4 2017 and has held it in 32 quarters since. The position peaked at $16.5M in Q3 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Horizon Investments held 35,484 shares of Amgen worth $12.8M as of Q2 2026.
  • Horizon Investments sold 3,704 Amgen shares in Q2 2026, an estimated $1.27M.
  • Amgen made up 0.14% of Horizon Investments's portfolio in Q2 2026, its #116 holding.
  • Horizon Investments first reported a position in Amgen in Q4 2017 and has held it in 32 quarters since.
  • Horizon Investments's Amgen position peaked at $16.5M in Q3 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.